The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as ...

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.

Moderna Inc (MRNA) stock saw a decline, ending the day at $33.76 which represents a decrease of $-1.01 or -2.90% from the prior close of $34.77. The stock opened at $34.75 and touched a low of $33.34 ...

As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...

Investing.com -- Moderna ...

Funding will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza ...

Sunburn has traditionally been attributed to UV-induced DNA damage. However, a new study by the University of Copenhagen and Nanyang Technological University, Singapore, reveals that RNA, another ...

Three students from Centreville High School in Clifton discovered a potentially harmful substance – DNA residues, or tiny ...